We provide a rich resource for dissecting the regulatory network that governs the developmental potency of EPSCs and exploring alternative strategies to capture totipotent stem cells in culture.
Aaron Viny, MD, assistant professor of medicine at VP&S, joins 16 recipients recognized for research that has the potential to advance the prevention, diagnosis and treatment of human disease.
Discovery of the CRISPR-associated protein Cas9 and its RNA-guided cleavage mechanism marks the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome.
